|
ACH-3422, A Novel HCV NS5B RNA Polymerase
Nucleotide Inhibitor, Demonstrates Improved Potency Over Sofosbuvir Against HCV Genotype-3 Replicons
In Vitro
|
|
|
Reported by Jules Levin
AASLD 2014
Yongsen Zhao, Steven Podos, Joanne Fabrycki, Dharaben Patel, Wengang Yang, Guangwei Yang, Jason Wiles, Avinash Phadke and Mingjun Huang
Achillion Pharmacueticals
![HCV1.gif](../images/021915/021915-1/HCV1.gif)
![HCV2.gif](../images/021915/021915-1/HCV2.gif)
![HCV3.gif](../images/021915/021915-1/HCV3.gif)
![HCV4.gif](../images/021915/021915-1/HCV4.gif)
|
|
|
|
|
|
|